Intellia Therapeutics Inc... (NTLA)
undefined
undefined%
At close: undefined
12.94
0.35%
After-hours Dec 13, 2024, 07:22 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue 36.27M 52.12M 33.05M 57.99M 43.10M 30.43M 26.12M 16.48M 6.04M -
Cost of Revenue 8.98M 7.57M 6.89M 150.41M 108.41M 89.11M 67.65M 31.84M 11.17M 1.66M
Gross Profit 27.30M 44.55M 26.16M -92.41M -65.31M -58.68M -41.53M -15.36M -5.13M -1.66M
Operating Income -515.29M -458.16M -267.85M -136.58M -106.37M -90.87M -69.56M -32.16M -13.41M -5.23M
Interest Income 49.83M 8.54M 1.28M 2.35M 6.83M 5.53M 2.01M 525.00K - -
Pretax Income -481.19M -474.19M -267.89M -134.23M -99.53M -85.34M -67.54M -31.63M -13.41M -14.31M
Net Income -481.19M -490.21M -259.72M -125.57M -92.70M -85.34M -67.54M -31.63M -12.40M -14.31M
Selling & General & Admin 116.50M 90.31M 71.10M 44.17M 41.06M 32.19M 28.02M 16.80M 8.28M 3.57M
Research & Development 435.07M 419.98M 229.81M 150.41M 108.41M 89.11M 67.65M 31.84M 11.17M 10.74M
Other Expenses - - - - - - - - - -
Operating Expenses 551.57M 510.29M 300.90M 194.58M 149.47M 121.30M 95.67M 48.64M 19.45M 12.65M
Interest Expense - 8.54M - - - - - - - -
Selling & Marketing Expenses - - - - - - - - - -
Cost & Expenses 551.57M 510.29M 300.90M 194.58M 149.47M 121.30M 95.67M 48.64M 19.45M 14.31M
Income Tax - 16.02M -8.17M -8.66M -6.83M 5.53M -2.99M -1.10M -1.01M -
Shares Outstanding (Basic) 88.77M 76.97M 70.89M 55.99M 47.25M 43.07M 36.01M 22.22M 17.66M 485.88K
Shares Outstanding (Diluted) 88.77M 76.97M 70.89M 55.99M 47.25M 43.07M 36.01M 22.22M 17.66M 485.88K
EPS (Basic) -5.42 -6.37 -3.66 -2.24 -1.96 -1.98 -1.88 -1.42 -0.7 -29.45
EPS (Diluted) -5.42 -6.37 -3.66 -2.24 -1.96 -1.98 -1.88 -1.42 -0.7 -29.45
EBITDA -506.31M -450.59M -260.96M -130.27M -100.78M -86.41M -66.56M -31.05M -13.08M -9.54M
Depreciation & Amortization 8.98M 7.57M 6.89M 6.31M 5.59M 4.46M 2.99M 1.10M 328.00K 4.50K